Key ECG Devices Market Players:
- GE Healthcare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Philips Healthcare
- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers
- Nihon Kohden
- Hill-Rom Holdings (Baxter)
- OSI Systems (Spacelabs)
- Schiller AG
- Boston Scientific
- Koninklijke Philips N.V.
- AliveCor, Inc.
- BPL Medical Technologies
- Biotronik
- Fukuda Denshi
- Mindray Medical
- ACS Diagnostics
- BSE Medical (Bionet)
- Cardiac Science
- Comen (Navitor)
The market is highly dominated by global MedTech pioneers, including GE Healthcare, Philips Healthcare, and Abbott Laboratories, which have captured the maximum revenue share. The incorporation and utilization of AI analytics in new instruments have become the key contributor to their market expansion strategy. In addition, they are adopting several advanced components to reduce the cost of final products, widening the range of options for every individual and hence increasing adoption in this field.
Below is the list of some prominent players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In 2026, the industry size of ECG devices is estimated at USD 7.8 billion.
ECG Devices Market size was valued at USD 7.3 billion in 2025 and is projected to reach USD 15.2 billion by the end of 2035, rising at a CAGR of 7.6% during the forecast period, i.e., 2026-2035.
North America industry is predicted to account for the largest share of 38.4% by 2035, owing to the high awareness of rare cancers and cross-border research collaborations in the region.
The major players in the market include SCHILLER AG, Nihon Kohden Corporation, Ambu A/S, Medtronic plc, Koninklijke Philips, ACS Diagnostics, Hill-Rom Holdings, BPL Medical Technologies, BioTelemetry, Inc.
